Navigation Links
NEW POLL: Majority of Allegan County Voters Oppose Prescription Only PSE Requirements
Date:9/30/2013

WASHINGTON, Sept. 30, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Allegan County, Michigan, voters conducted by Magellan Strategies and underwritten by CHPA. The poll, which surveyed 726 Allegan County voters between September 25th and 26th , found that a 62-percent-majority of Allegan County residents oppose a proposed law that would require all consumers to obtain a doctor's prescription before buying safe and effective cold and allergy medicines containing pseudoephedrine (PSE).

"The findings of the recent Allegan County poll are consistent with what we've seen in polls conducted across Michigan and throughout the country," said Scott Melville, president and chief executive officer of CHPA. "The same pattern has emerged in every state that we've surveyed: the majority of consumers oppose the prescription-only approach because it leads to significant economic burdens produced by unnecessary time off work and additional copays."

Allegan County officials are currently considering legislation that would implement a prescription requirement for popular cold and allergy medicine containing pseudoephedrine within the county limits. The proposal is set to be discussed at a September 30th town hall meeting, yet it has already come under fire from residents who recognize it as an overreach of government power.

"Mandating a prescription requirement at the local level is not an effective solution to stop the illegal sale of pseudoephedrine.  Rather than pursue a policy that would burden responsible taxpayers, city leaders should work with their state delegation to focus on balanced solutions that penalize criminals, not law-abi
'/>"/>

SOURCE The Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NEW POLL: Michigan Voters Oppose Prescription-Only Requirements on Cold and Allergy Medicines Containing Pseudoephedrine
2. Poll: Over One Million Seniors Have Problems with Medicare Preferred Pharmacy Drug Plans
3. NEW POLL: Tennessee Voters Strongly Oppose Making Popular Cold and Allergy Meds Prescription Only
4. The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles
5. Majority of Springfield Voters Oppose Prescription Only PSE Requirements
6. The Majority of Surveyed Gastroenterologists in the EU5 Identify Remicade as Their Most Preferred Biologic for the Treatment of Ulcerative Colitis
7. New National Survey Shows Majority of Americans Confident About Choosing Health Coverage
8. Allscripts adopts majority voting policy for directors
9. BD Completes Sale of Majority of Discovery Labware Unit
10. MinuteClinic Signs Clinical Collaboration with Baptist Health Care for Clinic Locations in Three-County Region of Northwest Florida
11. Orange County Hospital System, Integrated Healthcare Holdings, Joins ApolloMed ACO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... EVANSTON, Ill. , Nov. 21, 2014  Heated ... prescription drug prices – from cancer treatments to Gilead,s ... and pharmaceutical leaders around the world questioning what it ... quality of care. And while drug ... the pharmaceutical industry – from both a general business ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... Chief Executive Officer, will be presenting at the 26 th ... Palace Hotel in New York . The ... 2:00 PM ET. In addition, Mr. Krakauer and Jorgen ... separate one-on-one meetings during the day. An ...
Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... - IgG1 monoclonal,antibodies developed by ImClone Systems ... total presentations at the recently concluded,98th Annual ... Research,(AACR), including seven oral presentations and 37 ... the focus of,two back-to-back oral presentations leading ...
... ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis ... discussed results from two pre-clinical studies ... and,rationale for combining nab-paclitaxel (ABRAXANE(R) for ... (albumin-bound)) with VEGF inhibitor drugs like,bevacizumab ...
Cached Medicine Technology:ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 2ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 3ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 4ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 5Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 ... creating picture-perfect smiles for patients in preparation for the ... to the fronts of teeth, look completely natural, and ... certain situations, veneers are also valued for their ability ... patients and can be used on one or several ...
(Date:11/21/2014)... 2014 (HealthDay News) -- The cost of diabetes care ... recent years, climbing to more than $322 billion annually, ... cost were seen with prediabetes care, which have risen ... percent, the researchers added. In 2012, excess medical ... than $1,000 for every American. That total includes $244 ...
(Date:11/21/2014)... November 21, 2014 Richard Wolfe, ... , will present advanced benefits administration strategies during ... Houston HR Leadership Summit. This Game Changer breakout ... industry to present cutting-edge solutions and best practices ... explain how real-time data exchange between health and ...
(Date:11/21/2014)... Saint Luke’s Mid America Heart ... Failure Gold-Plus Quality Achievement Award for implementing specific ... Association/American College of Cardiology Foundation in their secondary ... With The Guidelines–Heart Failure is a quality improvement ... up-to-date, research-based guidelines with the goal of speeding ...
(Date:11/21/2014)... November 21, 2014 The typical Thanksgiving ... calorie dishes, plenty of gravy and a myriad of ... the best time of year to begin losing weight? ... has uncovered the secret to losing unhealthy, embarrassing and ... holiday recipes. , The insight to Diet Doc’s calorie ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4
... in this group , WEDNESDAY, June 2 (HealthDay News) -- ... of developing prostate cancer than white men, but now a ... likely to develop aggressive forms of the disease. , Researchers ... whites -- whose prostates were removed at the Durham Veterans ...
... ... maker of the life’sDHA™ brand, Martek Biosciences Corporation (NASDAQ: MATK) announced today that Norman ... selected as the recipient of the Alex Leaf Distinguished Scientist Award for 2010. ... Columbia, Md. (Vocus) ...
... ... in the last several years. ,Global Launch Management, a product launch management company, offers ... traditional marketing, the product launch marketing model has been very successful for many 60 ... ...
... say , WEDNESDAY, June 2 (HealthDay News) -- A ... for a kind of brain tumor in children, researchers report. ... 20 percent of childhood brain cancer cases. Treatment, which can ... at five years to 70 percent, but the tumors remain ...
... donations have more than doubled since the institution of grassroots ... published in the May issue of the Journal of ... of minority donors is expected to reach 35 percent, up ... organ transplant in 1954, the shortage of organ donors has ...
... reporting new evidence that capsaicin, the stuff that gives chili ... buildup by triggering certain beneficial protein changes in the body. ... appears in ACS, monthly Journal of Proteome Research . ... obesity is a major public health threat worldwide, linked to ...
Cached Medicine News:Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 2Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 3Health News:Traditional Marketing is Dead! GLM Creates a Sales Spike in Under 60 Days Stops Business Failure; Provides Startup Funding 2Health News:Grassroots programs to encourage minority organ donation prove successful 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: